Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

144.01
Delayed Data
As of Dec 02
 +1.62 / +1.14%
Today’s Change
133.64
Today|||52-Week Range
176.85
-11.29%
Year-to-Date
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab
Nov 30 / Zacks.com - Paid Partner Content
Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today
Nov 30 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks to Buy in 2017
Nov 29 / MotleyFool.com - Paid Partner Content
Arrowhead Pharma Shares Destroyed by Development Announcement
Nov 30 / TheStreet.com - Paid Partner Content
'Brain training' healthcare digital games target dementia
Nov 29 / FT.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Amgen
Nov 30 / MotleyFool.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close142.39
Today’s open142.29
Day’s range141.50 - 144.91
Volume3,517,303
Average volume (3 months)3,496,489
Market cap$107.1B
Dividend yield2.78%
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+11.34%
Earnings growth (next 5 years)+8.15%
Revenue growth (last year)+6.49%
P/E ratio14.4
Price/Sales5.83
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.42-0.58%
BIIBBiogen+1.41+0.48%
ILMNIllumina Inc+0.18+0.14%
TECHBio-Techne Corp-0.47-0.44%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs